A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary Aldosteronism
A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary Aldosteronism
Recruiting · NCT07007793 · Registry updated 2026-07-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary Aldosteronism | adrenal gland disorder, adrenal gland hyperfunction, endocrine system disorder, hyperaldosteronism, primary aldosteronism | Recruiting | Phase 3 | 2026-07-06 | NCT07007793 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AstraZeneca | 806 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||